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Blood pressure is an important parameter in the evaluation of cardiovascular
function and status. It has generally been accepted that blood pressure control is
significantly affected by the resistance in the peripheral vessels and cardiac output
that correspond to the blood pressure control during systole and diastole, respec-
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Purpose: Photoplethysmography (PPG) is a noninvasive optical technology that
detects changes in blood volume in the vascular system. This study aimed to
investigate the possibilities of monitoring the cardiovascular system status by using
PPG. Materials and Methods: Forced hemodynamic changes were induced using
cardiac stimulants; dopamine and epinephrine, and PPG components were
recorded by a noninvasive method at the peripheral blood vessels. The results were
compared among 6 dogs. Endotracheal intubation was performed after an intra-
muscular injection of 25 mg/kg ketamine sulfate, and anesthesia was maintained
with 2% enflurane. After stabilizing the animals for 15 min, 16 mg/mL diluted
dopamine was injected into a vein for 2 min at 20 µg/kg˙min
-1 by using an infusion
pump. Thereafter, the infusion pump was stopped, and 1 mg epinephrine was
injected intravenously. Fluid administration was controlled to minimize preload
change in blood pressure. Results: After stimulant administration, systolic blood
pressure (SBP) and diastolic blood pressures (DBP) increased. The direct current
(DC) component, which reflects changes in blood volume, decreased while the
alternating current (AC) component, which reflects changes in vascular com-
pliance and resistance, increased. The correlation coefficient between SBP and the
foot of the DC component was 0.939 (p < 0.01), while it was 0.942 (p < 0.01) for
DBP and the peak of the DC component. The AC component could predict the
increase in vascular resistance from a stable pulse blood volume, even with inc-
reased pulse pressure. Conclusion: These results support the possibility that PPG
components may be used for easy and noninvasive measurement of hemodynamic
changes in the cardiovascular system.
Key Words: Photoplethysmography, invasive blood pressure, cardiovascular
system, blood volume, vascular resistance and compliance,
epinephrine, dopamine
Received: October 6, 2008
Revised: July 30, 2009
Accepted: August 6, 2009
Corresponding author: Hyungro Yoon, Ph.D.
Department of Biomedical Engineering, 
Yonsei University, 234 Meaji, Heungeup, 
Wonju 220-710, Korea.
Tel: 82-33-760-2807, Fax: 82-33-763-1953
E-mail: hryoon@yonsei.ac.kr
∙The authors have no financial conflicts of
interest.
© Copyright:
Yonsei University College of Medicine 2010
This is an Open Access article distributed under the
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/
licenses/by-nc/3.0) which permits unrestricted non-
commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited.
INTRODUCTIONtively. The cardiovascular system is a closed loop compris-
ing the heart and blood vessels; its internal pressure is con-
tinuously changing due to changes in blood volume and
vascular capacity. On the basis of this physiological foun-
dation, change in blood pressure and vessel status can be
evaluated by monitoring the change in blood flow.
1-3
Photoplethysmography (PPG) is a noninvasive optical
technology that detects changes in blood volume in the vas-
cular system. It has been widely used with medical equip-
ment that measures oxygen saturation and that can evaluate
cardiac output, arterial resistance, aortic elasticity, blood
pressure, heart rate, and other peripheral vascular disea-
ses.
4-6 A PPG signal is derived as a voltage signal generated
by a photo detector for light with changes in the flow of
blood; the light passes though the skin, arterial blood, venous
blood, tissue, etc.
7 A PPG can be divided into 2 compo-
nents: alternating current (AC) and direct current (DC)
component. The AC component of a wave implies pulsed
blood flow in the artery, which is influenced by the contrac-
tion and relaxation of the heart. The DC component repre-
sents static blood flow in the artery, vein, and tissue.
7-10
According to these previous studies, it is possible that
the DC component reflects change in blood volume, and
the AC component reflects vascular compliance and resis-
tance. Moreover, a PPG can provide useful physiological
information for evaluating the cardiovascular system along
with blood pressure. Previous studies have researched these
relationships with non-invasive blood pressure, general
blood pressure range or only one PPG component. 
In this study, forced hemodynamic changes were induced
via commonly used cardiac stimulants in an animal experi-
ment, and the PPG components recorded by a noninvasive
method at the peripheral blood vessels were compared
with the invasive blood pressure (IBP) findings. In
addition, the cause of a blood pressure change induced by
the infusion of dopamine and epinephrine was evaluat-ed
via a pharmacological approach. Thus, the possibility of
evaluating the cardiovascular system by using the PPG
components was investigated.
The experimental protocol was reviewed and approved by
the Animal Research Committee of the Wonju College of
Medicine, Yonsei University.
Subjects and experimental protocol
The study subjects included 6 dogs (20-25 kg), regardless
of the gender. After an intramuscular injection of 25 mg/kg
ketamine sulfate, endotracheal intubation was performed
and anesthesia was maintained with 2% enflurane. Each
anesthetized dog was fixed on a stand, and its respiration
was maintained using an artificial ventilator. Fig. 1A
shows the positions of the direct blood pressure sensor for
IBP, electrocardiogram (ECG) electrodes, and PPG sensors.
IBP was monitored by inserting a microtipped catheter into
the right femoral artery, and the PPG signal was measured
at the dog’s tail because the tail is one of easiest areas to
set a PPG sensor and one of best areas to acquire precious
vascular information. The overall experimental procedure
is shown in Fig. 1C. The experimental animals were
stabilized for 15 min after the experimental preparation
was completed. To induce a hemodynamic change, 16
mg/mL of diluted dopamine was injected into a vein for 2
min at the rate of 20 µg/kg ˙min
-1 by using an infusion
Incheol Jeong, et al.
Yonsei Med J   http://www.eymj.org    Volume 51   Number 3   May 2010 346
MATERIALS AND METHODS
Fig. 1.(A) Sensor positions in the animal experiment. (B) External view and cross section of contact pressure-fixed type sensor. (C) Flow diagram showing the course of
experiment in this study. RA, right arm; LA, left arm; RL, right leg; PPG, photoplethysmograph; LED, light emitting diode.
AC
Bpump. Thereafter, the infusion pump was ceased, and 1 mg
of epinephrine was intravenously injected in order to
induce a stronger hemodynamic change. 
Expected hemodynamic changes
Considering the pharmacological properties of dopamine
and epinephrine, these two drugs are established as impor-
tant frequently used cardiac stimulants.
11-13 Dopamine (3, 4-
dihydroxyphenylethylamine) is a precursor of norepine-
phrine and is produced by the decarboxylation of dihy-
droxyphenylalanine (dopa) during the biosynthesis of
catecholamines.
14 It is metabolized by monoamine oxidase
(MAO) and catechol O-methyl transferase (COMT), and it
becomes inactive after destruction in the digestive tract.
During dopamine medication, depending on the concentra-
tion, it exhibits different hemodynamic effects on dopami-
nergic, β1-adrenergic, and α1-adrenergic receptors. In most
cases, 160 mg dopamine is diluted in 100 mL of glucose
solution to obtain a concentration of 16 mg/mL for i.v. admi-
nistration. Different hemodynamic effects are exhibited
depending on the dose.
15,16 At a low dose (0.5-3.0 µg/kg ˙
min
-1), it mainly activates the dopaminergic receptor. At an
intermediate dose (3.0-7.0 µg/kg˙min
-1), dopamine activa-
tes the β1-adrenergic receptors to increase the heart rate
(HR) and cardiac output. At a high dose (> 10 µg/kg˙min
-1),
it mostly activates the α1-adrenergic receptors in the vessels,
and vascular constriction raises the blood pressure.
15,17,18
Epinephrine is a hormone secreted from the adrenal
medulla and is also known as adrenaline. Epinephrine is
accepted as a stimulation transmitter in the sympathetic
nerve, and epinephrine injection excites the β1-adrenergic
receptors in the heart to enhance myocardial contraction
via positive inotropic effects. Epinephrine increases the
HR via positive chronotropic action and enhances the
irritability of the cardiac muscle via positive bathmotropic
action. Its positive dromotropic action reduces stimulus
conduction.
19,20 Thus, cardiac output increases; however,
cardiac efficiency is reduced because of the remarkable
increase in oxygen consumption in the cardiac muscle.
13 A
significant reduction in systole than in diastole is observed
in the heart activated by epinephrine. Conclusively, the
total number of diastoles per minute increases with the
cardiac output.
12,18 However, if the HR is increased beyond
the physiological range, sufficient relaxation will not
occur; therefore, cardiac output will be reduced. Epine-
phrine in the vessels simultaneously activates the α-
receptor and β-receptors, but the activation of the α-
receptors is dominant and manifested as vasoconstriction.
Epinephrine is the strongest agent for increasing blood
pressure, and an abrupt increase in blood pressure is
noticed depending on the i.v. injection dose.
19 This rise in
blood pressure results from increased cardiac output due to
enhanced myocardial contraction and the HR. Moreover,
SBP increases abruptly to a value more than DBP, i.e.,
pulse pressure increases.
11,13,20
Data collection and analysis
The PPG signal is influenced by external factors such as
the distance between the light source and photodetector,
contact force, and temperature.
5 In our experiment, a band
type PPG sensor (MAX-N, Nellcor, Pleasanton, CA,
USA) was used to monitor the change in the waveforms
obtained from the cardiovascular system and minimize the
effect of contact force.
10 To minimize the effect of tem-
perature,
21 ambient temperature was maintained at 24 ±
0.7˚C. To measure the PPG signal, an infrared light-emit-
ting diode (LED) with a center wavelength of 890 nm and
a photodetector with a center wavelength of 900 nm were
used. The signal was measured in the transmission mode.
The DC component of the PPG signal detected by the
photodetector, using an analog low-pass filter with a cut-
off frequency of 20 Hz. Then the AC component of the
PPG signal was extracted using a high-pass filter with a
cut-off frequency of 0.15 Hz. Power Lab (ML880, ADIns-
truments, Bella Vista, NSW, Australia) with a 12-bit A/D
converter was used to acquire signals at a sampling rate of
200 Hz per channel and digitize them. A constant current
source circuit was used to drive the LED, and the ampli-
fication ratio was kept constant.
A pressure transducer (SPC-350, Millar Instruments,
Houston, TX, USA) was used to measure the IBP, and the
signals were acquired at a sampling rate of 200 Hz using
Power Lab. The acquired data was additionally analyzed
with LabVIEW 8.2 (National Instruments). The HR was
detected from the ECG signal using a set of automatic
programming routines involving the zero-crossing-Based
QRS detection algorithm.
22 SBP, DBP, and PPG compo-
nents were detected using a set of automatic programming
routines involving low-pass filtering, zero-phase filtering,
differentiation, and threshold peak/foot detection algorithm.
Fig. 2 shows that the PPG signal has the following com-
ponents: transmission current (IT), absorption current (IA),
pulsation current (IS), and cycle (R), which are related to
the total current (I0). IT is inversely related to tissue blood
volume, while IS is proportional to increase in blood
volume during contraction periods. R is the actual cardiac
cycle. Transmission and pulsation currents (IT and IS) usually
fluctuate in a low-frequency range such as the respiration
rate. Low-frequency fluctuation in the cardiac cycle is
mainly controlled by the sympathetic nerve.
23 Variation in
blood flow (IA and IS) is generated due to vasoconstriction
and vasodilation, both of which are significantly affected
by the sympathetic nervous system.
24 Therefore, PPG signal
specifically provides information regarding blood volume
Evaluation of the Cardiovascular System
Yonsei Med J   http://www.eymj.org    Volume 51   Number 3   May 2010 347Incheol Jeong, et al.
Yonsei Med J   http://www.eymj.org    Volume 51   Number 3   May 2010 348
as well as that on blood pumping and its transportation
status.
5 The IT component is used in studies that measure
blood volume, while the IS component validates the exis-
tence of resistance in studies on the vascular compliance
with the cardiovascular system, such as hypertension.
25
Low-frequency fluctuation of IT and IS originates from
automatic variations in the sympathetic nerve activity.
Activation of the sympathetic nerve leads to vasoconstric-
tion. This is the result of low compliance (high resistance)
in the arterial system and reduction in blood flow in tissue,
which results in the increase of IT and reduction of IS.
9,26-28
To monitor the hemodynamic change induced after the
drug injection, the HR, SBP, and DBP were measured
every 30 sec for 15 min. For normalization, these parame-
ters were also measured for 30 sec before the drug injection.
The absolute values for the DC and AC signals in the
PPG were in different ranges because of the anatomical
differences in the measured area for each subject. To
compare the results of all the subjects under the same con-
ditions, the average value for 30 sec before the injection
was set at 1 and the average value for every 30 sec was
normalized to analyze the 15-min data. These were used
for comparing the changes in the PPG signal components
with IBP pressure changes. With regard to the values of
the PPG components, transmission current during systole
(ITsys) and transmission current during diastole (ITdia) were
detected from the foot and peak of the DC signal, respec-
tively. Pulsation current (IS) was analyzed by the amplitude
of the AC signal.
Statistical analysis
The statistical program used in this study was SPSS 12.0
(SPSS Inc, Chicago, IL, USA) for Windows. Statistical
analyses were performed to evaluate the difference in
response of data between two points of drug administration
time for IBP, HR and PPG components by the Student t-
test. The changes in the IBP, HR, and PPG components
were expressed as means with standard deviations. Pear-
son’s correlation coefficients were evaluated via the cor-
relation analyses of the PPG components and IBP. For all
Fig. 2.(A) IBP and PPG waveform from animal experimentation. (B) PPG components for analyzing. Just before 23 : 20, dog’s tail moved so it caused
a temporary fluctuation in PPG components. However, our data analysis focused from Cardiac stimulation. IBP, invasive blood pressure; PPG,
photoplethysmograph; DC, direct current; AC, alternating current.
ABstatistical analyses, p< 0.05 was considered significant.
Variation in IBP & HR
During the first 2 min of dopamine injection at the rate of
20 µg/kg˙min
-1, SBP increased from 92.3 ± 12.69 mmHg
to 108.7 ± 20.23 mmHg, while DBP increased from 66.1 ±
10.75 mmHg to 81.8 ± 18.22 mmHg. After cessation of
dopamine administration, blood pressure slightly reduced.
After the intravenous (i.v.) injection of epinephrine, SBP,
and DBP significantly increased from 102.6 ± 18.44
mmHg to 214.5 ± 23.82 mmHg and from 76.7 ± 18.28
mmHg to 153.0 ± 15.17 mmHg, respectively. Blood
pressure was observed to be a maximum 2-3 min after the
injection of epinephrine. In addition, the pulse pressure,
i.e., the difference between SBP and DBP, also increased.
Evaluation of the Cardiovascular System
Yonsei Med J   http://www.eymj.org    Volume 51   Number 3   May 2010 349
Fig. 3.Response of blood pressure and heart rate to intravenous infusion and injection of cardiac stimulants. Systolic blood pressure (Systolic) and
diastolic blood pressure (Diastolic) were monitored continuously by an invasive method. Heart rate was calculated from ECG. Points represent
average values over a 30 sec period. Data shown as mean and SD. *p < 0.05, **p < 0.01: significant increase / decrease. IBP, invasive blood
pressure; HR, heart rate; ECG, echocardiogram.
Fig. 4. Response of PPG components (IT: foot and peak of the DC component of PPG, IS: amplitude of the AC component of PPG) to intravenous
infusion and injection of cardiac stimulants. PPG were continuously measured by a non-invasive method, and normalized in order to compare the
results of all the subjects under the same conditions. Points represent average values over a 30 sec period. Data shown as mean and SD. *p< 0.05,
**p< 0.01: significant increase / decrease. PPG, photoplethysmograph; DC, direct current; AC, alternating current.
RESULTSThe HR before drug injection was 91.4 ± 12.69 bit/min,
and the maximum HR was 122.9 ± 13.75 bit/min at 4 min
after drug injection. During the injection of dopamine, the
HR tended to show a consistent elevation. After the i.v.
injection of epinephrine, the HR increased for 1 min and
then reduced slightly (Fig. 3).
Variation in the PPG Components
Before injection, the average values for 30 sec of DC and
AC components of PPG were set at 1. After the injection,
the average values for every 30 sec were normalized. After
the drug injection, the changes in ITsys (foot of the DC com-
ponent of PPG) and ITdia (peak of the DC component of
PPG), which reflect changes in blood volume, were minimal
with values of 0.70 ± 0.035 and 0.71 ± 0.035, respectively,
at 5-6 min. The variations in IS (amplitude of the AC com-
ponent of PPG), which reflect changes in vascular com-
pliance and resistance, were maximized with the value of
1.024 ± 0.273 at 11-13 min (Fig. 4).
In regards to the variation in IT (the DC component of
PPG) according to change in IBP in all the subjects, an
increase in IBP indicated a significant reduction in ITsys and
ITdia. In addition, the correlation coefficient between ITsys
and SBP as shown in Table 1 was 0.939 (p < 0.01). It was
0.942 (p < 0.01) for DBP and ITdia. From these findings, a
high correlation could be determined between IBP change
and variation in the DC component of PPG (Fig. 5, Table 1).
This study aims to investigate the relationship between
IBP and PPG components. The major purpose of this
study was to investigate the possibility of monitoring the
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DISCUSSION
Table 1.Correlation and Significant Coefficients between IBP and PPG Component (n = 180)
Heart rate Systolic Diastolic ITsys ITdia
Systolic Pearson Correlation 0.487* 1.000
Sig. (2-tailed) 0.000
Diastolic Pearson Correlation 0.586* 0.982* 1.000
Sig. (2-tailed) 0.000 0.000
ITsys Pearson Correlation - 0.426* - 0.939* - 0.936* 1.000
Sig. (2-tailed) 0.000 0.000 0.000
ITdia Pearson Correlation - 0.434* - 0.938* - 0.942* 0.998* 1.000
Sig. (2-tailed) 0.000 0.000 0.000 0.000
IS Pearson Correlation 0.061 - 0.103 - 0.144 0.061 0.097
Sig. (2-tailed) 0.414 0.170 0.053 0.415 0.193
IBP, invasive blood pressure; PPG, photoplethysmograph; DC, direct current; AC, alternating current.
*Correlation is significant at the 0.01 level (2-tailed). Foot of the DC component of PPG (ITsys), peak of the DC component of PPG (ITsys), 
amplitude of the AC component of PPG (IS).
Fig. 5.Relationship between invasive blood pressure (IBP) and the DC component of PPG (IT). (A) Systolic blood pressure vs. foot of the DC component of PPG (ITsys). (B)
Diastolic blood pressure vs. peak of the DC component of PPG (ITsys). PPG, photoplethysmograph; DC, direct current.
ABstatus of the cardiovascular system by using a noninvasive
and inexpensive optical device, and provide information
regarding the same. The change in the cardiovascular
system due to cardiac stimulants, such as a change in IBP
and the PPG components, was detected and analyzed by
the presented animal experiments. The results indicate that
the PPG components have a clinical potential to monitor
the blood volume, the vessel resistance, and blood pressure.
Therefore, a noninvasive and easy monitoring method for
the evaluation of cardiovascular function was proposed.
At a high dose, dopamine enhances myocardial con-
tractility and cardiac output through increased HR, result-
ing in an increase in SBP. In addition, DBP increases due
to enhanced vasoconstriction.
15,19 For the first 2 min of
dopa-mine infusion, SBP and DBP showed an identical
increase with the HR. This indicated a distinctive reaction
of dopamine.
After the epinephrine injection, we confirmed that the
increase in SBP was more than that in DBP. Thus, pulse
pressure increased. Hence, dopamine and epinephrine, the
experimental cardiac stimulants, were confirmed to increase
the HR. Among the hemodynamic reactions, the change in
the HR was faster than that in blood pressure (Fig. 3).
The measured signals in our animal experiment were the
IBP and PPG. A PPG signal measures the transmission of
light through tissue as a function of time. Due to the incre-
ment in blood volume in the tissue during systole, the PPG
signal shows low transmission. In addition, light transmis-
sion is pulsating along with the cardiac cycle (Fig. 2).
9
Increased blood pressure due to dopamine and epine-
phrine can be analyzed by the increase in cardiac output
based on pharmacological basis.
18,29 Therefore, reduction in
ITsys and ITdia by the injection of dopamine and epinephrine
can be explained by the increase in cardiac output. IS,
which corresponds to vascular compliance, did not reveal
any significant change after the dopamine and epinephrine
injection. Even though after the injection of epinephrine
the pulse pressure increased, a constant IS can be explained
by vasoconstriction. In addition, the maximum variation in
IS was found at 11-13 min, and it can be elucidated by the
physiological relaxation of the peripheral vessels to reduce
increased blood pressure (Fig. 4). On the basis of this result,
we confirmed the possibility that a change in the cardio-
vascular system can be detected by measuring the PPG
components noninvasively.
Hemodynamic variations induced by dopamine and
epinephrine could be confirmed by the increase in the HR
and blood pressure, as shown in previous studies. Direct
and indirect changes in blood pressure due to dopamine
and epinephrine and indirect changes in the vascular
condition due to the hemodynamic variations were com-
pared and analyzed through the animal experiment. 
Previous studies on the effects of medical agents on the
cardiovascular system have reported that a rise in blood
pressure is induced by increased static volume of blood in
the vessels of the measurement area.
11-13 Our results are in
close agreement with those of previous studies. Variation
in the DC component of PPG, which was noninvasively
measured at the periphery, could be confirmed to have signi-
ficant relationships with the IBP (ITsys vs. systolic: r = - 0.939,
p< 0.01; ITdia vs. diastolic: r = - 0.942, p< 0.01) (Table 1).
Together with the DC component, the AC component of
PPG, which reflects vascular compliance and resistance,
can show the physiological change in the cardiovascular
system. Therefore, the AC component can predict increase
and reduction in vascular resistance. 
The undeniable advantage of PPG lies in its noninvasi-
veness and minimal restriction to patients.
10 In addition,
PPG in conjunction with pulse oximetry, which is usually
used for patient monitoring, can predict the change as well
as the pattern of change in the cardiovascular status.
5 Mo-
reover, PPG can be obtained from various locations in the
human body, is rather inexpensive, and is a small-sized
portable optical device.
30,31
Thus, it fulfills the developmental conditions for a per-
sonal health monitoring and mobile physiological monitor-
ing device. Although absolute accuracy in evaluating the
cardiovascular system may not be achieved, PPG compo-
nents may be useful for indirect monitoring of the cardio-
vascular function and status. Analysis results of PPG com-
ponents along with physiological changes induced by
medical agents will provide useful clinical information to a
doctor.
The limitation of this study is that these results come
from an animal experiment, but not from the human
cardiovascular system. Furthermore, clinical trials require
multiple restrictions, and the preliminary study was con-
ducted via animal testing. In addition, the corresponding
data was gathered from 6 dogs, which was a relatively
small number of samples. Finally, only 2 cardiac stimulants
were used to induce the change in the cardiovascular
system, i.e., increase in the blood pressure.
Future studies will be required to ascertain the clinical
applications of PPG components. Varied status changes
such as vasodilation, reduced blood volume, reduced blood
pressure, etc., should be induced in a large number of
subjects with varying ages, and normal groups should be
compared with the groups with disorders of the cardio-
vascular system. In addition, clinical trials on human pati-
ents within a range of safe and ethical treatment will
enhance the value of this research. A device that can
directly measure the resistance or elasticity of blood vessels
along with blood flow may provide a more profound
authenticity of PPG components through comparative
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as temperature and contact force was controlled in our ex-
periment, but the evaluation and optimization of the rest-
ricting conditions should be performed after considering
comprehensive external factors to enhance the clinical
significance of this study. 
In conclusion, photoplethysmography is a noninvasive,
simple, and inexpensive optical technology for monitoring
changes in blood flow in the peripheral vessels. In this
study, hemodynamic changes were forcefully induced.
The IBP, HR, and PPG components were measured and
analyzed in 6 dogs. In summary, the current study indi-
cates that the DC component of PPG is inversely propor-
tional to static blood volume in the vessels and tissues. In
addition, the AC component of PPG shows subtle changes
in the arterial system due to cardiac contraction and relaxa-
tion and provides information regarding vascular comp-
liance and resistance. Therefore, these results support the
possibility that the PPG components may be used for easy
and noninvasive measurement of hemodynamic changes
in the cardiovascular system such as blood pressure.
Further studies on PPG components will strengthen their
potential for use in clinical applications.
This study was supported by a grant of the Korea Health
21 R&D Project, Ministry of Health & Welfare, Republic
of Korea (A020602). 
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